• 1. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 2. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082
• 3. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738

Compound CAS No. 1379892-25-7: 2-Amino-3-(2,4-difluorophenyl)propan-1-ol; Hydrochloride

The compound with CAS No. 1379892-25-7, known as 2-Amino-3-(2,4-difluorophenyl)propan-1-ol; Hydrochloride, is a fascinating molecule that has garnered significant attention in the fields of organic chemistry and pharmacology. This compound is characterized by its unique structure, which includes an amino group, a hydroxyl group, and a difluorophenyl substituent, all of which contribute to its diverse chemical properties and potential applications.

Recent studies have highlighted the importance of fluorinated aromatic compounds in drug discovery and development. The presence of the 2,4-difluorophenyl group in this molecule has been shown to enhance its pharmacokinetic properties, including improved bioavailability and reduced toxicity. These findings underscore the potential of this compound as a lead molecule for the development of novel therapeutic agents.

The synthesis of 2-Amino-3-(2,4-difluorophenyl)propan-1-ol; Hydrochloride involves a multi-step process that typically begins with the preparation of the corresponding amine intermediate. Researchers have employed various methodologies, including nucleophilic substitution and reductive amination, to optimize the synthesis pathway. The hydrochloride salt form is particularly advantageous due to its enhanced solubility and stability under physiological conditions.

In terms of biological activity, this compound has demonstrated potent activity in several in vitro assays targeting key enzymes and receptors involved in various disease states. For instance, studies have shown that it exhibits significant inhibitory effects on certain kinases, making it a promising candidate for the treatment of cancers and inflammatory disorders. Furthermore, its ability to modulate G-protein coupled receptors (GPCRs) suggests potential applications in the development of treatments for neurological disorders.

The structural versatility of this compound also makes it an attractive substrate for further chemical modifications. Researchers have explored the incorporation of additional functional groups to enhance its pharmacodynamic properties or to target specific biological pathways more effectively. Such modifications are expected to expand its therapeutic potential across a wide range of indications.

In conclusion, the compound with CAS No. 1379892-25-7, or 2-Amino-3-(2,4-difluorophenyl)propan-1-ol; Hydrochloride, represents a valuable addition to the arsenal of chemical tools available for drug discovery and development. With its unique structure, favorable pharmacokinetic properties, and diverse biological activities, this molecule continues to be a focal point for researchers seeking innovative solutions in the field of medicinal chemistry.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)